Amblyopia (Lazy Eye)

Amblyopia is a developmental disorder of the visual cortex resulting from abnormal binocular interaction or form deprivation during the critical period of visual development (birth to 7-10 years), causing reduced best-corrected visual acuity (BCVA) of 20/30 or worse with no organic ocular cause beyond the inciting condition. Prevalence is 2-5% in children, making it the most common cause of monocular visual impairment in young adults. Pathogenesis involves cortical neural plasticity: the dominant eye's input dominates the visual cortex, while the amblyopic eye's input is suppressed. Subtypes include strabismic (ocular misalignment with constant suppression), anisometropic (unequal refractive error >1.5 D causing one image to be blurrier), deprivation (cataract, severe ptosis, corneal opacity blocking visual input), combined strabismic-anisometropic, and meridional (uncorrected astigmatism).

Diagnosis requires age-appropriate visual acuity testing (Teller acuity cards, Cardiff cards, HOTV, Snellen), comprehensive eye exam with cycloplegic refraction, and detection of underlying cause. Critical to diagnose by age 4-5 for optimal treatment; vision screening programs (photoscreening, Welch Allyn Spot, PlusOptiX) at well-child visits identify cases. Differential diagnosis must exclude organic causes (optic nerve hypoplasia, retinal disease, neurologic causes); persistent visual deficit despite treatment should prompt re-evaluation.

Treatment principles: (1) treat underlying cause (cataract surgery for deprivation, optical correction for refractive amblyopia, strabismus surgery as needed); (2) force use of the amblyopic eye through occlusion (patching the better eye 2-6 hours daily depending on severity—PEDIG studies established 2 hours/day effective for moderate amblyopia, 6 hours for severe), pharmacologic penalization (atropine 1% drops daily or weekend-only to dominant eye), or Bangerter foils; (3) emerging therapies include dichoptic/binocular video games (e.g., Vivid Vision), virtual reality, and contrast-balanced movies that train both eyes simultaneously. Critical period treatment (age 4-7) yields best outcomes; ages 7-12 still respond but slower; older children and adolescents may show partial response with intensive therapy. Compliance is the major challenge; education, gamification, and family support are essential. Maintenance therapy may be needed to prevent regression.